N-Methylhistamine, Random, Urine




Test Mnemonic

UMHISR

CPT Codes

  • 82542 - QTY (1)
  • 82570 - QTY (1)

Includes

  • N-Methylhistamine, Random, Ur
  • Creatinine, Random, Ur

Performing Laboratory

Mayo Clinic Dpt of Lab Med & Pathology

FDA Category

Laboratory Developed Test


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
5 mLUrine, randomClean container (No preservatives) RefrigeratedCollect within a few hours of onset of symptoms.

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
3 mL     

Stability

Environmental Condition Description
Refrigerated28 days (preferred)
Ambient14 days
Frozen28 days

Days Performed

Tue, Thu

Turnaround Time

4 - 8 days

Methodology

Name Description
Colorimetric Enzyme Assay 
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) 

Reference Range

Special Info

Patient must not be taking monoamine oxidase inhibitors (MAOIs) or aminoguanidine as these medications increase N-methylhistamine (NMH) levels. Collect the random urine specimen within a few hours of onset of symptoms.

Clinical Info

Useful for screening and monitoring mastocytosis and disorders of systemic mast-cell activation, such as anaphylaxis and other forms of severe systemic allergic reactions using random urine specimens. Monitoring therapeutic progress in conditions that are associated with secondary, localized, low-grade persistent, mast-cell proliferation and activation such as interstitial cystitis. Patients with chronic mast cell activation often have chronically elevated N-methylhistamine (NMH) levels and will sometimes have intermittent NMH elevations. In these cases, a 24-hour urine collection is preferred [see N-Methylhistamine, Urine (MHISTA)]. Cautions: While an average North American diet has no effect on urinary N-methylhistamine (NMH) levels, mild elevations (approximately 30%) may be observed on very histamine-rich diets. This problem is more pronounced if random urine specimens are used and collected following a histamine-rich meal. NMH levels may be depressed in individuals who have an alteration in the histamine-N-methyl transferase gene, which encodes the enzyme that catalyzes NMH formation. This alteration results in an amino acid change that decreases the rate of NMH synthesis. When N-acetylcysteine is administered at levels sufficient to act as an antidote for the treatment of acetaminophen overdose, it may lead to falsely decreased creatinine results.